Synthesis method for key intermediate, analogue or salt of ticlopidine

A synthetic method, the technology of anagrelide, applied in the key intermediates of anagrelide, the synthesis of analogues and their salts, analogues and salts and their synthesis, and the field of N-glycine ester, can solve the problem that the yield is only 75%, Complicated operation and other problems, to achieve the effect of high total yield, overcoming the long route, and mild and easy-to-control conditions

Active Publication Date: 2013-10-02
SHANGHAI PUKANG PHARMA
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0019] This method has simple steps, but the content of components and water content must be s

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method for key intermediate, analogue or salt of ticlopidine
  • Synthesis method for key intermediate, analogue or salt of ticlopidine
  • Synthesis method for key intermediate, analogue or salt of ticlopidine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] The preparation of embodiment 1N-(6-nitro-2,3-dichlorobenzyl) glycine

[0047] After mixing 35kg of methanol and 39kg of 2mol / l sodium hydroxide aqueous solution, add 9.2kg of glycine, stir for 20min, dissolve 15.4kg of 2,3-dichloro-6-nitrobenzaldehyde in 35kg of methanol, drop the solution Add it to the above reaction system, control the temperature at 20-25°C, stir for 40min after the dropwise addition, cool down to 0-5°C, and add 120kgNaBH in batches 4 , heated up to 20-25°C and stirred until the reaction was complete, evaporated the methanol under reduced pressure, adjusted the pH to 5 with 2mol / l hydrochloric acid, spin-dried and recrystallized with 30kg of water to obtain 20.78kg of off-white solid with a yield of 97.2%.

Embodiment 2

[0048] The preparation of embodiment 2N-(6-nitro-2,3-dichlorobenzyl) glycine methyl ester

[0049] In a 100L reactor, add 10.0kg N-(6-nitro-2,3-dichlorobenzyl)glycine to 50kg methanol, add 5kg concentrated sulfuric acid, heat and reflux until the reaction is complete, recover methanol under reduced pressure, add 10kg saturated NaHCO 3 The aqueous solution was extracted with ethyl acetate, the organic layer was dried, and the solvent was recovered to obtain 99.8 kg of N-(6-nitro-2,3-dichlorobenzyl) glycine methyl ester, with a yield of 95%.

Embodiment 3

[0050] The preparation of embodiment 3N-(6-nitro-2,3-dichlorobenzyl) glycine methyl ester hydrochloride

[0051] In a 100L reaction kettle, add 10kg of N-(6-nitro-2,3-dichlorobenzyl)glycine to 50kg of methanol, cool down to 0-5°C, add 4.7kg of thionyl chloride dropwise, and the dropwise addition is completed , heated to reflux until the reaction was complete, methanol was reclaimed under reduced pressure, the residue was added to 20 kg of ethyl acetate for beating, and filtered to obtain 11.46 kg of N-(6-nitro-2,3-dichlorobenzyl) glycine hydrochloride. The rate is 97%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a synthesis method for a key intermediate, analogue or salt of ticlopidine. The synthesis method comprises the following steps of: (1) adding 6-nitro-2,3-dichlorobenzaldehyde and glycine or corresponding substituted glycine into a solution and adding a reducing agent to completely react to obtain N-(6-nitro-2,3-dichlorobenzyl) glycine and an analogue thereof; and (2) completely reacting the N-(6-nitro-2,3-dichlorobenzyl) glycine and the analogue thereof under the action of a catalyst to obtain the key intermediate, analogue or salt of the ticlopidine, wherein the solution in the step (1) is a mixed solution of a protic solvent and an inorganic base, and the reducing agent is one or a mixture of sodium borohydride, potassium borohydride, lithium borohydride, sodium cyanoborohydride and acetic sodium borohydride. The method is simple in operation, mild and easily-controlled in condition, convenient for aftertreatment, environment-friendly and higher in yield, and is a brand new efficient industrial synthesis method for the key intermediate, analogue or salt of the ticlopidine.

Description

technical field [0001] The present invention relates to quinazoline compounds, in particular to anagrelide key intermediates, analogues, salts and synthesis methods thereof, namely N-(6-nitro-2,3-dichlorobenzyl)glycinate, Synthesis of analogues and their salts. Background technique [0002] Anagrelide hydrochloride (IV) was developed by Roberts Pharmaceuticals and was approved by the FDA in 1997 as a drug listed in the United States. This drug can be used to treat essential thrombocythemia and polycythemia vera complicated with thrombocytosis. It can also Applied to other myeloid proliferative diseases, such as myelofibrosis and osteoproliferative syndrome accompanied by abnormal platelet increase, its mechanism of action is cyclic adenosine monophosphate phosphodiesterase III inhibitor, which can inhibit the formation and aggregation of platelets at high concentrations . This drug was originally used to inhibit platelet aggregation and has antithrombotic effect, but in re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C227/18C07C229/14
Inventor 汪迅李新涓子李勇刚高艳吕兴红沈小良俞翔施乐乐
Owner SHANGHAI PUKANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap